Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7179892 Humanized antibodies that recognize beta amyloid peptide

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 12, 2003
Date of Patent
February 20, 2007
Patent Application Number
10388389
Patent Citations Received
‌
US Patent 11779629 Compositions comprising cyclic peptides derived from an A-beta peptide
‌
US Patent 11905318 Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
0
‌
US Patent 11970522 Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
0
‌
US Patent 12071472 Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7179892
Patent Primary Examiner
‌
Janet L. Andres

Find more entities like US Patent 7179892 Humanized antibodies that recognize beta amyloid peptide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo